C21 · Pharmaceuticals · 8 measures · 3 regions
Pharmaceutical R&D investment
United States: 125,986 million USD in 2023, +8.5% on 2022.
- 125,986 million USD Pharmaceutical and medicine manufacturing total R&D performance · United States · 2023
- +8.5% vs 2022
- 8Measures
- 3Countries · 2022–2024
Verified 27 Sep 2026 · 3 publishers · 10 records · Next period 2024
Pharmaceutical and medicine manufacturing total R&D performance
The best-covered measure of pharmaceutical R&D investment. Every point opens its record; the values are one click away under the chart.
Pharmaceutical and medicine manufacturing total R&D performance
United States, 2022 to 2023
Every measure of pharmaceutical R&D investment
8 measures: the same subject cut by product, segment, basis or form. Each has its own page with every record.
| Measure | Latest | Where and when | Records |
|---|---|---|---|
| Health sector research and development investment growth rate | 9.1% | Japan, 2024 | 2 |
| Pharmaceutical and medicine manufacturing total R&D performance | 125,986 million USD | United States, 2023 | 2 |
| Pharmaceutical and medicine manufacturing company-funded R&D | 114,225 million USD | United States, 2023 | 1 |
| Pharmaceutical and medicine manufacturing externally funded R&D | 11,761 million USD | United States, 2023 | 1 |
| Pharmaceutical and medicine manufacturing R&D funded by domestic companies | 2,104 million USD | United States, 2023 | 1 |
| Pharmaceutical and medicine manufacturing R&D funded by foreign companies | 9 billion USD | United States, 2023 | 1 |
| Pharmaceutical and medicine manufacturing R&D funded by other external sources | 79 million USD | United States, 2023 | 1 |
| Pharmaceutical business enterprise research and development expenditure | 8.7 billion GBP | United Kingdom, 2023 | 1 |
Pharmaceutical R&D investment by country
A page for every country with at least three records:
Frequently asked questions
What does pharmaceutical R&D investment measure?
Total capital and operational expenditure allocated to research and development activities.
What is the latest pharmaceutical and medicine manufacturing total R&D performance?
United States: 125,986 million USD in 2023, +8.5% on 2022.
Which countries does this pharmaceutical R&D investment data cover?
3 countries, with a page each for United States.
Where does the data come from?
From 4 documents published by European Commission, NCSES, ONS. Every figure links to its record, which quotes the sentence or table row it was read from.
How often is it updated?
Annual; the newest figure covers 2023, and the next release should cover 2024.
Sources
4 documents from 3 publishers. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| The 2025 EU Industrial R&D Investment Scoreboard | European Commission | 22 Dec 2025 | 2 |
| Business R&D Performance in the United States Increases to $722 Billion in 2023 | NCSES | — | 6 |
| Discovery: R&D Activity and Research Publications | NCSES | — | 1 |
| Business enterprise research and development, UK | ONS | — | 1 |
Cite this page
Published under CC BY 4.0: free to reuse, including commercially, with attribution to StatOrigin and the original publisher. To cite one figure, open its record.
StatOrigin. (2026). Pharmaceutical R&D investment statistics [Data set]. Retrieved September 29, 2026, from https://statorigin.org/statistics/pharmaceutical-r-and-d-investment
"Pharmaceutical R&D investment statistics." StatOrigin, 2026, https://statorigin.org/statistics/pharmaceutical-r-and-d-investment. Accessed 29 Sep. 2026.
StatOrigin. "Pharmaceutical R&D investment statistics." Data set, 2026. Accessed September 29, 2026. https://statorigin.org/statistics/pharmaceutical-r-and-d-investment.
@misc{statorigin_pharmaceutical_r_and_d_investment_2026, title = {Pharmaceutical R\&D investment statistics}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/pharmaceutical-r-and-d-investment}, note = {Data set. Accessed 2026-09-29} }